Literature DB >> 3115332

Establishment of an interleukin 2-dependent human T cell line from a patient with T cell chronic lymphocytic leukemia who is not infected with human T cell leukemia/lymphoma virus.

T Hori1, T Uchiyama, M Tsudo, H Umadome, H Ohno, S Fukuhara, K Kita, H Uchino.   

Abstract

We established an interleukin 2 (IL-2)-dependent human T cell line, Kit 225, from a patient with T cell chronic lymphocytic leukemia (T-CLL) with OKT3+, -T4+, -T8- phenotype. Southern blot analysis showed that Kit 225 is not infected with human T cell leukemia/lymphoma virus (HTLV) type I or II, and is probably derived from the major clone in the fresh leukemic cells. Kit 225 cells express a large amount of IL 2 receptors constitutively and their growth is absolutely dependent on IL 2. No other stimuli, such as lectins or antigens, are required for maintaining the responsiveness to IL 2. As abnormal IL 2 receptor expression was also seen originally in the fresh leukemic cells, the establishment of this cell line with IL 2 suggests that IL 2-mediated T cell proliferation is involved in the leukemogenesis of some cases of HTLV-negative T-CLL.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3115332

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  54 in total

1.  Detection of channel proximity by nanoparticle-assisted delaying of toxin binding; a combined patch-clamp and flow cytometric energy transfer study.

Authors:  Bálint Rubovszky; Péter Hajdú; Zoltán Krasznai; Rezsõ Gáspár; Thomas A Waldmann; Sándor Damjanovich; László Bene
Journal:  Eur Biophys J       Date:  2005-03       Impact factor: 1.733

2.  Cytotoxic effects of two organotin compounds and their mode of inflicting cell death on four mammalian cancer cells.

Authors:  Armando Varela-Ramirez; Margaret Costanzo; Yazmin P Carrasco; Keith H Pannell; Renato J Aguilera
Journal:  Cell Biol Toxicol       Date:  2010-10-31       Impact factor: 6.691

3.  Human and murine IL2 receptors differentially respond to the human-IL2 component of immunocytokines.

Authors:  Zulmarie Perez Horta; Swetha Saseedhar; Alexander L Rakhmilevich; Lakeesha Carmichael; Jacquelyn A Hank; Margaret Boyden; Stephen D Gillies; Paul M Sondel
Journal:  Oncoimmunology       Date:  2018-05-07       Impact factor: 8.110

4.  Intensity correlation-based calibration of FRET.

Authors:  László Bene; Tamás Ungvári; Roland Fedor; László Sasi Szabó; László Damjanovich
Journal:  Biophys J       Date:  2013-11-05       Impact factor: 4.033

5.  OX40 signaling renders adult T-cell leukemia cells resistant to Fas-induced apoptosis.

Authors:  Akane Kunitomi; Toshiyuki Hori; Michiyuki Maeda; Takashi Uchiyama
Journal:  Int J Hematol       Date:  2002-10       Impact factor: 2.490

6.  Epidermal growth factor receptor controls glycogen phosphorylase in T cells through small GTPases of the RAS family.

Authors:  Francisco Llavero; Miriam Luque Montoro; Alazne Arrazola Sastre; David Fernández-Moreno; Hadriano M Lacerda; Luis A Parada; Alejandro Lucia; José L Zugaza
Journal:  J Biol Chem       Date:  2019-01-15       Impact factor: 5.157

7.  Membrane Potential Distinctly Modulates Mobility and Signaling of IL-2 and IL-15 Receptors in T Cells.

Authors:  Éva Nagy; Gábor Mocsár; Veronika Sebestyén; Julianna Volkó; Ferenc Papp; Katalin Tóth; Sándor Damjanovich; György Panyi; Thomas A Waldmann; Andrea Bodnár; György Vámosi
Journal:  Biophys J       Date:  2018-05-10       Impact factor: 4.033

Review 8.  Implication of the HTLV-I bZIP factor gene in the leukemogenesis of adult T-cell leukemia.

Authors:  Yorifumi Satou; Masao Matsuoka
Journal:  Int J Hematol       Date:  2007-08       Impact factor: 2.490

9.  Qualitatively different T cell phenotypic responses to IL-2 versus IL-15 are unified by identical dependences on receptor signal strength and duration.

Authors:  Abhinav Arneja; Hannah Johnson; Laura Gabrovsek; Douglas A Lauffenburger; Forest M White
Journal:  J Immunol       Date:  2013-12-02       Impact factor: 5.422

10.  STAT5 regulation of BCL10 parallels constitutive NFkappaB activation in lymphoid tumor cells.

Authors:  Zsuzsanna S Nagy; Matthew J LeBaron; Jeremy A Ross; Abhisek Mitra; Hallgeir Rui; Robert A Kirken
Journal:  Mol Cancer       Date:  2009-08-26       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.